Verve Therapeutics (VERV) Competitor Comparison
We are evaluating the key criteria listed to compare Verve Therapeutics (VERV) against its competitors in the Biotechnology industry.
Market Capitalization
103 / 368Gross Profits
247 / 278Total Revenue
190 / 300EBITDA
288 / 337Free Cashflow
292 / 352Quick Ratio
48 / 357Earnings per Share
233 / 359Dividend yield
0 / 6Total Cash
64 / 358Performance 3 years
289 / 368Performance 5 years
231 / 368Performance 10 years
207 / 368Linearity 3 years
218 / 368Linearity 5 years
157 / 368Linearity 10 years
156 / 368Total Rank
59 / 368Dividend Rank
17 / 368Valuation Rank
37 / 368Piotroski Rank
97 / 368Muliplier Rank
232 / 368Dividend yield - VERV ranking 0 / 6
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.